Target
26S proteasome
3 abstracts
Abstract
A phase 2 evaluation of daratumumab-based induction therapy in patients with multiple myeloma with severe renal insufficiency.Org: Emory University School of Medicine and Winship Cancer Institute, UPMC Cancer Center - Hillman Cancer Center, Winship Cancer Institute of Emory University,
Abstract
Bortezomib-induced cardiotoxicity: Real-world data from a single-center.Org: LSU Health Shreveport, Louisiana State University Shreveport, Feist-Weiller Cancer Center at LSUHSC-Shreveport, Louisiana State University (Shreveport) Program at Feist-Weiller Cancer Center,
Abstract
In hospital outcomes and mortality predictors of multiple myeloma on stroke hospitalizations: A multivariable logistic regression study on the National Inpatient Sample Database.Org: Louis A Weiss Memorial Hospital, Weiss Memorial Hospital, Rawalpindi Medical University, Onslow Memorial Hospital, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH,